Literature DB >> 15378558

Effects of beta-estradiol and propofol on the 4-methylumbelliferone glucuronidation in recombinant human UGT isozymes 1A1, 1A8 and 1A9.

Yuji Mano1, Takashi Usui, Hidetaka Kamimura.   

Abstract

The effects of beta-estradiol and propofol on human UGT1A1, 1A8 and 1A9 activities were investigated using 4-methylumbelliferone (4-MU) as a substrate for glucuronidation. The formation of 4-MU glucuronide (4-MUG) from 4-MU, in recombinant human UGT 1A1, 1A8 and 1A9 was determined using HPLC with fluorescence detection. The glucuronidation activity of 4-MU was the highest in UGT1A9 with an apparent K(m) value of 8.3 microM, while that in UGT1A1 and 1A8 was linear to at least 100 microM. beta-estradiol had potent inhibitory effects on UGT1A9 as well as on UGT1A1 with IC(50) values of 2.1 and 7.2 microM, respectively. Propofol inhibited UGT1A9 activity with an IC(50) of 55 microM, while the IC(50) value was much higher for UGT1A8. In contrast, beta-estradiol and propofol activated 4-MU glucuronidation in UGT1A1 and 1A8, respectively. This study therefore indicates that the use of beta-estradiol as a specific inhibitor for UGT1A1 should be used with care in the identification of UGT isozymes responsible for glucuronidation in human liver microsomes. Copyright (c) 2004 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15378558     DOI: 10.1002/bdd.418

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  8 in total

1.  Contribution of UDP-glucuronosyltransferases 1A9 and 2B7 to the glucuronidation of indomethacin in the human liver.

Authors:  Yuji Mano; Takashi Usui; Hidetaka Kamimura
Journal:  Eur J Clin Pharmacol       Date:  2007-01-24       Impact factor: 2.953

2.  Identification of human UDP-glucuronosyltransferase responsible for the glucuronidation of niflumic acid in human liver.

Authors:  Yuji Mano; Takashi Usui; Hidetaka Kamimura
Journal:  Pharm Res       Date:  2006-06-21       Impact factor: 4.200

3.  Alternative transcript splicing regulates UDP-glucosyltransferase-catalyzed detoxification of DIMBOA in the fall armyworm (Spodoptera frugiperda).

Authors:  Bhawana Israni; Katrin Luck; Samantha C W Römhild; Bettina Raguschke; Natalie Wielsch; Yvonne Hupfer; Michael Reichelt; Aleš Svatoš; Jonathan Gershenzon; Daniel Giddings Vassão
Journal:  Sci Rep       Date:  2022-06-20       Impact factor: 4.996

4.  Glucuronidation of dihydrotestosterone and trans-androsterone by recombinant UDP-glucuronosyltransferase (UGT) 1A4: evidence for multiple UGT1A4 aglycone binding sites.

Authors:  Jin Zhou; Timothy S Tracy; Rory P Remmel
Journal:  Drug Metab Dispos       Date:  2009-12-09       Impact factor: 3.922

5.  Functional characterization of low-prevalence missense polymorphisms in the UDP-glucuronosyltransferase 1A9 gene.

Authors:  Kristine C Olson; Ryan W Dellinger; Qing Zhong; Dongxiao Sun; Shantu Amin; Thomas E Spratt; Philip Lazarus
Journal:  Drug Metab Dispos       Date:  2009-07-09       Impact factor: 3.922

6.  Dietary supplement 4-methylumbelliferone: an effective chemopreventive and therapeutic agent for prostate cancer.

Authors:  Travis J Yates; Luis E Lopez; Soum D Lokeshwar; Nicolas Ortiz; Georgios Kallifatidis; Andre Jordan; Kelly Hoye; Norman Altman; Vinata B Lokeshwar
Journal:  J Natl Cancer Inst       Date:  2015-04-13       Impact factor: 13.506

7.  Glucuronidation of drugs in humanized UDP-glucuronosyltransferase 1 mice: Similarity with glucuronidation in human liver microsomes.

Authors:  Yuki Kutsuno; Kyohei Sumida; Tomoo Itoh; Robert H Tukey; Ryoichi Fujiwara
Journal:  Pharmacol Res Perspect       Date:  2013-09-03

Review 8.  Structure and Protein-Protein Interactions of Human UDP-Glucuronosyltransferases.

Authors:  Ryoichi Fujiwara; Tsuyoshi Yokoi; Miki Nakajima
Journal:  Front Pharmacol       Date:  2016-10-24       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.